Wave Life Sciences Total Debt Growth & History (WVE)

Wave Life Sciences's total debt was $17.8M for fiscal 2025.

View full Wave Life Sciences company overview

Wave Life Sciences annual total debt history

Wave Life Sciences annual total debt

Fiscal yearPeriod endedTotal debtChangeGrowth
20252025-12-31$17.8M−$7.6M−30.07%
20242024-12-31$25.4M−$6.7M−20.90%
20232023-12-31$32.1M−$5.5M−14.61%
20222022-12-31$37.6M$7.7M+25.73%
20212021-12-31$29.9M$611,000+2.08%
20202020-12-31$29.3M−$3.2M−9.96%
20192019-12-31$32.5M
20172017-12-31$16,000−$62,000−79.49%
20162016-12-31$78,000−$62,000−44.29%
20152015-12-31$140,000

Wave Life Sciences total debt trends

Over the last five fiscal years, Wave Life Sciences's total debt decreased from $29.3M to $17.8M, a change of −$11.5M. The latest reported quarter, Q2 2026, shows $43.6M.

About the metric

What total debt means

Total debt measures a company’s reported interest-bearing borrowing obligations at a reporting-period end. It can include short-term borrowings, current maturities, long-term debt, and finance lease obligations when they are included in the company’s debt facts.

Calculation and source

SEC-reported and combined total debt

TickerStat uses a reported aggregate debt value when available. Otherwise, it combines non-overlapping current and noncurrent debt facts from SEC filings. Total liabilities are not treated as debt, and missing debt is not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Wave Life Sciences source filings ↗

Community posts

It’s quiet here.

No posts about WVE yet. Start the conversation.

Write the first post